Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
EVQLV
EVQLV is a biotechnology company leveraging machine learning, computational biology, and software engineering to accelerate and reduce the cost of therapeutic antibody discovery. Their proprietary…
EVQLV
EVQLV is a biotechnology company leveraging machine learning, computational biology, and software engineering to accelerate and reduce the cost of therapeutic antibody discovery. Their proprietary…
TL;DR
What they do: AI-driven in silico platform for de novo antibody discovery and engineering (Abtique/HyperBind)
Headquarters: New York, NY (additional presence in Miami, FL)
Founded: 2019
Team size: ~7 employees
Investors: Includes Endeavor Miami, Synapse, Bantam Group, Techstars, and others
Company Overview
Problem Domain
Therapeutic antibody discovery and engineering — reducing time and cost of candidate generation and optimization.
Founded
2019
Industry
Biotechnology
Tech Stack
Funding Track Record
Public profiles list a last round classified as non-equity assistance with Endeavor Miami noted as lead investor.
Investor Signal
“Has multiple investors including Endeavor Miami, Synapse, Bantam Group, Techstars, Sidecar Angels, Space Florida, Synapse, TBD Angels”